To compare the effect of Gomutrayukta Erand Tail Basti and its oral administration in two group of 20 patients of Gridhrasi w.s.r. to Sciatica

A comparative clinical study to evaluate the efficacy of Gomutrayukta Erand Tail Basti and its oral administration in the management of Gridhrasi w.s.r. to sciatica - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/098785

Enrollment

Registered

2025-12-10

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G00-G99- Diseases of the nervous system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: The presence of Ruka, Toda, Stambh and Spandan in the Sphik, Kati, Uru, Janu Jangha and Pada. Tenderness along Sciatica nerve. Patient of either sex between age group 20-70 years will be included. SLR test in affected leg as objective measure for diagnosis and assessment will be taken.

Exclusion criteria

Exclusion criteria: Contraindicated for Oral administration of Gomutrayukta Erand Taila and Basti. Known cases of any major illness i.e. DM, TB, AIDS, Covid-19 and Malignancy. Surgical indication such as progressive neurological deficit. Pregnancy, Anemia, Gout, Leprosy, Kamala, Atisar. Age below 20 years and above 70 years

Design outcomes

Primary

Measure	Time frame
1. Relief in sign and symptom of gridhrasi i.e. Ruk(pain), Stambh(Stiffness),Toda(pricking sensation), Aruchi(anorexia), Tandra(lethargy), Gaurav(heaviness). 2. Relief in low back pain symptoms like pulling pain, stiffness, pricking sensationTimepoint: 60 days	—

Secondary

Measure	Time frame
SLR TestTimepoint: 60 days	—

Countries

India

Contacts

Public ContactDr Akhilesh Prasad Singh

Government Ayurvedic College and Hospital

drapsinghpatna@gmail.com8002680973

Outcome results